BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34140581)

  • 21. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.
    Bendotti C; Tortarolo M; Suchak SK; Calvaresi N; Carvelli L; Bastone A; Rizzi M; Rattray M; Mennini T
    J Neurochem; 2001 Nov; 79(4):737-46. PubMed ID: 11723166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amelioration of Amyotrophic Lateral Sclerosis in SOD1
    Epperly MW; Fisher R; Rigatti L; Watkins S; Zhang X; Hou W; Shields D; Franicola D; Bayir H; Wang H; Thermozier S; Henderson A; Donnelly C; Wipf P; Greenberger JS
    In Vivo; 2019; 33(3):675-688. PubMed ID: 31028184
    [No Abstract]   [Full Text] [Related]  

  • 23. Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS.
    Barbeito AG; Martinez-Palma L; Vargas MR; Pehar M; Mañay N; Beckman JS; Barbeito L; Cassina P
    Neurobiol Dis; 2010 Mar; 37(3):574-80. PubMed ID: 19914377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1.
    Yang Y; Gozen O; Vidensky S; Robinson MB; Rothstein JD
    Glia; 2010 Feb; 58(3):277-86. PubMed ID: 19672971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
    Han Y; Ripley B; Serada S; Naka T; Fujimoto M
    PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice.
    Park S; Kim HT; Yun S; Kim IS; Lee J; Lee IS; Park KI
    Exp Mol Med; 2009 Jul; 41(7):487-500. PubMed ID: 19322031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
    Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
    Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS.
    Suzuki M; McHugh J; Tork C; Shelley B; Klein SM; Aebischer P; Svendsen CN
    PLoS One; 2007 Aug; 2(8):e689. PubMed ID: 17668067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS.
    Bravo-Hernandez M; Tadokoro T; Navarro MR; Platoshyn O; Kobayashi Y; Marsala S; Miyanohara A; Juhas S; Juhasova J; Skalnikova H; Tomori Z; Vanicky I; Studenovska H; Proks V; Chen P; Govea-Perez N; Ditsworth D; Ciacci JD; Gao S; Zhu W; Ahrens ET; Driscoll SP; Glenn TD; McAlonis-Downes M; Da Cruz S; Pfaff SL; Kaspar BK; Cleveland DW; Marsala M
    Nat Med; 2020 Jan; 26(1):118-130. PubMed ID: 31873312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis.
    Bowerman M; Salsac C; Coque E; Eiselt É; Deschaumes RG; Brodovitch A; Burkly LC; Scamps F; Raoul C
    Hum Mol Genet; 2015 Jun; 24(12):3440-56. PubMed ID: 25765661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
    Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis.
    Tada S; Okuno T; Yasui T; Nakatsuji Y; Sugimoto T; Kikutani H; Sakoda S
    J Neuroinflammation; 2011 Feb; 8():19. PubMed ID: 21345177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS.
    Kadoyama K; Funakoshi H; Ohya W; Nakamura T
    Neurosci Res; 2007 Dec; 59(4):446-56. PubMed ID: 17935811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis.
    Schütz B
    Neurobiol Dis; 2005 Oct; 20(1):131-40. PubMed ID: 16137574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice.
    Hossaini M; Cardona Cano S; van Dis V; Haasdijk ED; Hoogenraad CC; Holstege JC; Jaarsma D
    J Neuropathol Exp Neurol; 2011 Aug; 70(8):662-77. PubMed ID: 21760539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis.
    Kang J; Rivest S
    J Cell Biol; 2007 Dec; 179(6):1219-30. PubMed ID: 18086918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.